UK CLL Forum. 2016. “Ibrutinib for relapsed/refractory Chronic Lymphocytic Leukemia: A UK and Ireland Analysis of Outcomes in 315 Patients”. Haematologica 101 (12). Pavia, Italy, 1563-72. https://doi.org/10.3324/haematol.2016.147900.